Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. Applications
  3. diabetes retinopathy
Show results for
Products
Services
Applications

Companies

News
Articles
Videos

Refine by
Locations

  • USA
  • Canada
  • Europe

  • Asia & Middle East
  • Australasia
  • Latin America
  • North America
Industries served

  • Medical / Health Care

Diabetes Retinopathy Product Applications

4 applications found

Therapy Solutions for Proliferative Diabetic Retinopathy

Therapy Solutions for Proliferative Diabetic Retinopathy

Navilas offers rapid pattern delivery at all available pulse lengths while enhancing selectivity with navigated pattern ...

ByOD-OS GmbH  based in  Teltow, GERMANY


Sustained-Release Drug Delivery Platforms for Retinal Diseases

Sustained-Release Drug Delivery Platforms for Retinal Diseases

Glaukos is developing multiple micro-invasive, bioerodible, sustained-release drug delivery platforms designed to be used in the treatment of various retinal disease, including age-related macular degeneration (AMD) and diabetic macular ...

ByGlaukos Corporation  based in  San Clemente, CALIFORNIA (USA)


Diabetic Macular Edema

Diabetic Macular Edema

Diabetic macular edema is a complication of diabetes caused by fluid accumulation in the macula, or central portion of the eye. The macula is filled with cones, the nerve cells that are responsible for sensing light. When the macula begins to fill with fluid, the ability of those cells to sense light is impaired, causing blurred vision that can be severe. Vision loss from DME can progress over a period of months and make it impossible to focus ...

ByLutronic Vision  based in  Billerica, MASSACHUSETTS (USA)


Retinal Vein Occlusion (RVO)

Retinal Vein Occlusion (RVO)

RVO is a chronic condition of the eye in which small blood clots form in the small veins that carry blood away from the retina. When this occurs, there is hemorrhage of blood from the blocked vessels into the surrounding retinal tissue leading to swelling (macular edema) and formation of new blood vessels (neovascularization). Left untreated, RVO typically leads to progressive deterioration of vision leading to permanent blindness. Risk factors for RVO include atherosclerosis, diabetes and high blood pressure. ...

ByCerevast Medical, Inc.  based in  Bothell, WASHINGTON (USA)

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical XPRT Industry Products
  • Medical XPRT Industry Software
  • Medical XPRT Industry Training
  • Medical XPRT Industry Services
  • Medical XPRT Industry Applications

Latest

  • Medical XPRT Industry News
  • Medical XPRT Industry Events

Publications

  • Medical XPRT Industry Articles
  • Medical XPRT Industry Books
  • Medical XPRT Industry Magazines
  • Medical XPRT Industry Downloads
  • Medical XPRT Industry Videos

Companies

  • Medical XPRT Industry Companies

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT